In this actionable webinar for quality leaders, we’ll reveal essential automation strategies and how to configure CAPA processes to match your unique business processes—without custom coding or IT dependencies. Learn how forward-thinking companies are leveraging configurable quality event management systems to dramatically reduce CAPA resolution...
For more than 15 years, SeerPharma has proudly collaborated with the Malaysian Organisation of Pharmaceutical Industries (MOPI) to design and deliver regular Good Manufacturing Practice (GMP) training programs for pharmaceutical and medical device manufacturers across Malaysia. These training sessions are endorsed by, and frequently attended by,...
Explore the critical role of digital transformation in asset management—an often overlooked but vital function for life sciences companies producing regulated products.
As a life sciences manufacturer, there’s mounting pressure to integrate artificial intelligence (AI) across the product lifecycle and capitalize on the opportunities this technology presents to the industry. Organizations face the complex challenge of balancing innovation with regulatory compliance.
Safe and effective adoption of AI can require...
The Parenteral Drug Association (PDA) is a leading global provider of science, technology and regulatory information and education for the pharmaceutical and biopharmaceutical community.
SeerPharma Senior GMP Consultant Michelle Peake has been invited to speak at PDA Annex 1 Implementation: Inspection Ready Workshop 2025, 17 - 18 June 2025 in ...
By 2030, it is projected that over 60% of the global population will reside in the Asia-Pacific region, with one in four individuals aged 60 or older1. This demographic shift, coupled with rising healthcare costs, an increase in chronic diseases, and a more discerning healthcare consumer base, is driving exceptional growth in the region’s...
For over 35 years, SeerPharma has served as a trusted partner to life science organisations across the Asia-Pacific (APAC) region, supporting them in navigating complex challenges related to Quality Assurance and GxP compliance.
With the mainstream support for SAP ECC6 ending in 2027 and extended maintenance available only until 2030 at an additional cost, Pharmaceutical and Medical Device manufacturers are facing a critical decision: how to upgrade their ERP systems in a way that meets both business goals and regulatory obligations. The move to SAP S/4HANA presents a...
SeerPharma is pleased to announce that Ian Lucas, Director and Training Manager, will be presenting at the ARCS Annual Conference 2025, to be held from 3–5 June at the International Convention Centre (ICC) in Darling Harbour, Sydney.
SeerPharma is proud to announce that one of its very own, Consultant and Lecturer Aaron Bennett, has been selected to participate in the 2025 Merck Innovation Cup as part of the Smart Manufacturing team. The event will be held at Merck’s global headquarters in Darmstadt, Germany, from 19 to 25 July.
Copyright © SeerPharma
